# Topical 5% Imiquimod Cream for Vulvar Paget's Disease

> **NCT02385188** · PHASE3 · COMPLETED · sponsor: **University Medical Center Nijmegen** · enrollment: 25 (actual)

## Conditions studied

- Paget Disease, Extramammary

## Interventions

- **DRUG:** Imiquimod
- **DRUG:** paracetamol
- **DRUG:** lidocaine in Vaseline ointment

## Key facts

- **NCT ID:** NCT02385188
- **Lead sponsor:** University Medical Center Nijmegen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-03
- **Final completion:** 2019-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385188, "Topical 5% Imiquimod Cream for Vulvar Paget's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02385188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*